Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026

Rhea-AI Summary

Insmed (Nasdaq: INSM) will release fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026. Management will host a conference call at 8:00 a.m. ET that day to discuss results and provide a business update.

Investors may dial domestic and international numbers with access code 7862189, or join a live webcast at www.insmed.com. A replay will be available by phone through February 26, 2026, and the webcast archive will remain on the investor site for 90 days.

News Market Reaction – INSM

-0.92%

1 alert

-0.92% News Effect

On the day this news was published, INSM declined 0.92%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Results date: February 19, 2026 Call time: 8:00 a.m. ET Replay end date: February 26, 2026 +5 more

8 metrics

Results date February 19, 2026 Fourth-quarter and full-year 2025 release date

Call time 8:00 a.m. ET Start time for the earnings conference call

Replay end date February 26, 2026 Phone replay availability through this date

Webcast archive 90 days Duration the webcast will remain available online

Current price $152.44 Price before this announcement

1-day move -3% Price change in the prior 24 hours

52-week high $212.75 Pre-news 52-week high level

52-week low $60.40 Pre-news 52-week low level

Market Reality Check

Price: $164.91 Vol: Volume 1,790,998 vs 20-da...

low vol

$164.91 Last Close

Volume Volume 1,790,998 vs 20-day average 2,740,152 (relative volume 0.65x) ahead of the call notice. low

Technical Shares at $152.44, trading above 200-day MA at $135.55 and 28.35% below 52-week high.

Peers on Argus

INSM was down 3% while key biotech peers showed mixed moves (e.g., BNTX +0.55%, ...

INSM was down 3% while key biotech peers showed mixed moves (e.g., BNTX +0.55%, ARGX -1.03%, GMAB -1.69%), suggesting stock-specific factors rather than a unified sector move.

Previous Conferences,earnings Reports

5 past events · Latest: Oct 15 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Oct 15	Q3 2025 call notice	Neutral	+1.3%	Scheduled Q3 2025 earnings release and investor call with webcast details.
Jul 24	Q2 2025 call notice	Neutral	+0.1%	Announced Q2 2025 results date and 8:00 a.m. ET conference call logistics.
Apr 23	Q1 2025 call notice	Neutral	-0.6%	Outlined Q1 2025 release timing and investor call access information.
Feb 10	FY 2024 call notice	Neutral	-2.3%	Set date for Q4 and full-year 2024 results and accompanying business update call.
Oct 17	Q3 2024 call notice	Neutral	-3.1%	Announced Q3 2024 results release and investor conference call schedule.

Pattern Detected

Past earnings call scheduling announcements under this tag saw modest moves, averaging -0.92%, indicating these logistics updates typically generate limited directional impact.

Recent Company History

Over the past year, Insmed has regularly announced quarterly and annual results calls, including Q3 2024, Q4 2024, and Q1–Q3 2025 events. These releases consistently set an 8:00 a.m. ET call time, detail dial-in information, and offer a 90-day webcast archive. Price reactions to these notices were mixed but generally modest, with an average move of -0.92%, suggesting the market treats them as routine disclosures rather than major catalysts.

Historical Comparison

-0.9% avg move · In the past five earnings-call scheduling notices tagged “conferences,earnings,” INSM’s average move...

conferences,earnings

-0.9%

Average Historical Move conferences,earnings

In the past five earnings-call scheduling notices tagged “conferences,earnings,” INSM’s average move was -0.92%, indicating today’s announcement fits a pattern of routine, low-impact disclosures.

Recurring quarterly and annual earnings call scheduling from 2024 through 2025, maintaining consistent timing, format, and 90-day webcast archiving.

Market Pulse Summary

This announcement sets the timetable for Insmed’s fourth-quarter and full-year 2025 results, with a ...

Analysis

This announcement sets the timetable for Insmed’s fourth-quarter and full-year 2025 results, with a conference call at 8:00 a.m. ET on February 19, 2026 and a 90-day webcast archive. Historically, similar “conferences,earnings” notices have led to modest average moves of -0.92%. Attention typically shifts to the actual numbers and pipeline commentary delivered on the call, which tend to be the true trading catalysts.

AI-generated analysis. Not financial advice.

BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 19, 2026, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through February 26, 2026, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two therapies approved to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-fourth-quarter-and-full-year-2025-financial-results-conference-call-on-thursday-february-19-2026-302679597.html

SOURCE Insmed Incorporated

FAQ

When will Insmed (INSM) report fourth-quarter and full-year 2025 results?

Insmed will release fourth-quarter and full-year 2025 results on Thursday, February 19, 2026. According to the company, management will discuss results on a conference call beginning at 8:00 a.m. ET the same day and provide a business update.

How can investors join the Insmed (INSM) earnings call on February 19, 2026?

Investors can join by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) and using access code 7862189. According to the company, a live webcast will also stream at www.insmed.com for remote participants.

Will Insmed (INSM) provide a webcast and replay of the February 19, 2026 call?

Yes. The call will be webcast live at www.insmed.com, and a replay will be available by phone through February 26, 2026. According to the company, the webcast archive will be posted in the Investor Relations section for 90 days.

What access code is required for the Insmed (INSM) earnings call and replay?

The access code for both the live call and replay is 7862189. According to the company, participants should reference this code when dialing the domestic or international conference and when accessing the replay by phone.

Where will Insmed (INSM) archive the February 19, 2026 earnings webcast?

Insmed will archive the webcast under the Investor Relations section at www.insmed.com for 90 days after the call. According to the company, the archived webcast will be available alongside other investor materials from the event.